-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of three new animal drug applications (NADAs) for roxarsone or carbarsone Type A medicated articles at the sponsor's request because the products are no longer manufactured or marketed.
DATES:
This rule is effective December 2, 2013.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, john.bartkowiak@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007, has requested that FDA withdraw approval of the following three NADAs because the products, used to manufacture Type B and Type C medicated feeds, are no longer manufactured or marketed: NADA 007-891 for 3-NITRO (roxarsone) Type A Start Printed Page 69993medicated articles, NADA 092-953 for Roxarsone Type A Medicated Articles, and NADA 010-285 for CARB-O-SEP (carbarsone) Type A medicated article.
Elsewhere in this issue of the Federal Register, FDA gave notice that approval of NADAs 007-891, 010-285, and 092-953, and all supplements and amendments thereto, is withdrawn, effective December 2, 2013. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect these voluntary withdrawals of approval.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects in 21 CFR Part 558
- Animal drugs
- Animal feeds
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:
Start PartPART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
End Part Start Amendment Part1. The authority citation for 21 CFR part 558 continues to read as follows:
End Amendment Part[Amended]2. In § 558.120, remove and reserve paragraphs (a)(1) and (d)(1)(i).
End Amendment Part Start Amendment Part3. In § 558.530, remove and reserve paragraphs (a) and (b); and revise the tables in paragraphs (d)(1) through (3) to read as follows:
End Amendment PartRoxarsone.* * * * *(d) * * *
(1) * * *
Roxarsone in grams per ton Combinations in grams per ton Indications for use Limitations Sponsor (i) [Reserved] (ii) 22.7 to 45.4 Chlortetracycline 10 to 50 Growing chickens: For increased rate of weight gain, improved feed efficiency, and improved pigmentation Feed continuously throughout growing period; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter 054771 (iii) 22.7 to 45.4 Chlortetracycline 100 to 200 Growing chickens: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter 054771 (iv) 22.7 to 45.4 Chlortetracycline 200 to 400 Growing chickens: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of chronic respiratory disease (CRD) and air sac infection caused by M. gallisepticum and Escherichia coli susceptible to chlortetracycline Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter 054771 (v) 22.7 to 45.4 Chlortetracycline 500 Growing chickens: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for reduction of mortality due to E. coli infections susceptible to chlortetracycline Feed continuously for 5 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter 054771 (2) * * *
Roxarsone in grams per ton Combinations in grams per ton Indications for use Limitations Sponsor (i) [Reserved] (ii) 22.7 to 45.4 Chlortetracycline 10 to 50 Growing turkeys: For increased rate of weight gain, improved feed efficiency, and improved pigmentation Feed continuously throughout growing period; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter 054771 Start Printed Page 69994 (iii) 22.7 to 45.4 Chlortetracycline 200 Growing turkeys: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter 054771 (iv) 22.7 to 45.4 Chlortetracycline 400 1. Growing turkeys: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of hexamitiasis caused by Hexamita meleagrides susceptible to chlortetracycline 2. Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter 054771 (v) 22.7 to 45.4 Chlortetracycline, 25 mg/lb body weight daily Growing turkeys: For increased rate of weight gain, improved feed efficiency, and improved pigmentation; and for control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline Feed continuously for 7 to 14 days; withdraw 5 days before slaughter; as sole source of organic arsenic; drug overdose or lack of water may result in weakness or paralysis of the legs Chlortetracycline as provided by No. 054771 in § 510.600(c) of this chapter 054771 (3) * * *
Start Printed Page 69995Roxarsone in grams per ton Combinations in grams per ton Indications for use Limitations Sponsor (i) [Reserved] (iii) [Reserved] (iv) 181.5 Chlortetracycline 10 to 50 Growing and finishing swine: For increased rate of weight gain and improved feed efficiency; and for treatment of swine dysentery Feed for not more than 6 consecutive days; if improvement is not observed, consult a veterinarian; withdraw 5 days before slaughter; as a sole source of organic arsenic; animals must consume enough medicated feed to provide a therapeutic dose 054771 (v) 181.5 Chlortetracycline 400 (to administer 10 mg/lb body weight) Growing and finishing swine: For the treatment of swine dysentery; and for treatment of bacterial enteritis caused by E. coli and S. choleraesuis and bacterial pneumonia caused by P. multocida susceptible to chlortetracycline Feed for not more than 6 consecutive days; if improvement is not observed, consult a veterinarian; withdraw 5 days before slaughter; as a sole source of organic arsenic; animals must consume enough medicated feed to provide a therapeutic dose 054771 * * * * *Dated: November 18, 2013.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2013-27917 Filed 11-21-13; 8:45 am]
BILLING CODE 4160-01-P
Document Information
- Effective Date:
- 12/2/2013
- Published:
- 11/22/2013
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 2013-27917
- Dates:
- This rule is effective December 2, 2013.
- Pages:
- 69992-69995 (4 pages)
- Docket Numbers:
- Docket No. FDA-2013-N-0002
- Topics:
- Animal drugs, Animal feeds
- PDF File:
- 2013-27917.pdf
- Supporting Documents:
- » FREEDOM OF INFORMATION SUMMARY NADA 130-185 AMPROL 25% and FLAVOMYCIN Amprolium and Bambermycins
- » FREEDOM OF INFORMATION SUMMARY Application Number 141-422 PACCAL VET-CA1 Paclitaxel for injection Powder for Injection Dog
- » FREEDOM OF INFORMATION SUMMARY NADA141-420 TILDREN tiludronate disodium Powder for injection Horse
- » FREEDOM OF INFORMATION SUMMARY NADA 141-361 PULMOTIL AC Tilmicosin Phosphate Aqueous Concentrate Swine
- » FREEDOM OF INFORMATION SUMMARY NADA 141-246 AQUAFLOR Florfenicol
- » Freedom of Information Summary NADA 141-288 EXCENEL RTU EZ Ceftiofur Hydrochloride
- » Freedom of Information Summary NADA 095-735 RUMENSIN 90 Monensin
- » Freedom of Information Summary NADA 141-406 NEXGARD Afoxolaner Chewable Tablet
- » Freedom of Information Summary ANADA 200-548 ACTOGAIN 45 Ractopamine Hydrochloride Cattle fed in confinement for slaughter
- » Freedom of Information Summary ANADA 200-542 ENGAIN 9 and ENGAIN 5 Ractopamine Hydrochloride Finishing Swine
- CFR: (2)
- 21 CFR 558.120
- 21 CFR 558.530